CMS advised Infarm, a Berlin-based food start-up, on their series D funding round, which raised USD 200 million. Existing and new investors are involved in the current investment. The start-up is now valued at well over USD 1 billion.
The additional capital will be used by the urban farming company to support its global growth strategy by building a global network of climate-resilient vertical farms. A new group structure with a holding company in the Netherlands underlines the internationalisation of the business, with the expansion in existing markets in the US, Europe and Japan as well the entry into new markets in Asia-Pacific and the Middle East.
CMS in the Netherlands, headed by Martijn van der Bie and Pieter van Duijvenvoorde, has advised Infarm on all legal aspects with respect to this new investment round. The investment round followed an internal cross-border restructuring of Infarm that was supported by CMS in the Netherlands and in Germany.
Related Experts
